Literature DB >> 6874903

In vitro evaluation of the BACTEC resin-containing blood culture bottle.

S M Smith, R H Eng.   

Abstract

The BACTEC resin-containing blood culture bottle (16B; Johnston Laboratories) was designed to bind antibiotics and to support bacterial growth. However, only modest increases in the recovery rates of pathogens have been found in clinical studies. This in vitro study evaluated the ability of the 16B to recover organisms from human serum containing clinically achievable concentrations of antibiotics. Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Haemophilus influenzae, Staphylococcus aureus, Streptococcus faecalis, and a viridans streptococcus were added to serum containing antibiotic(s), and at various time intervals of antibiotic exposure, portions were removed and inoculated into both the 16B and the 6B (conventional aerobic) bottles. The studies of the kinetics of killing of the bacterial strains by the various antibiotics showed a good correlation between those combinations of bacteria-antibiotic(s) which produced slow killing and the combinations of bacteria-antibiotic(s) which were recovered preferentially in the 16B bottles. Low recovery rates were noted when the antibiotics killed the organisms rapidly. The indications for use of the resin-containing blood culture bottle should be limited to those situations in which the patient is receiving antibiotics and the bacteremia is suspected to involve a pathogen which is killed slowly by the administered drug(s) or when the bacteremia is continuous. The failure of the BACTEC 16B blood culture bottle to recover organisms may in part reflect the bactericidal activity of the antibiotics administered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874903      PMCID: PMC272812          DOI: 10.1128/jcm.17.6.1120-1126.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Rapid isolation of bacteria from septicemic patients by use of an antimicrobial agent removal device.

Authors:  C Wallis; J L Melnick; R D Wende; P E Riely
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

2.  The antimicrobial removal device. A microbiological and clinical evaluation.

Authors:  A J Wright; R L Thompson; C A McLimans; W R Wilson; J A Washington
Journal:  Am J Clin Pathol       Date:  1982-08       Impact factor: 2.493

3.  Evaluation of the Antibiotic Removal Device.

Authors:  M D Appleman; R S Swinney; P N Heseltine
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

4.  In vitro antibiotic removal and bacterial recovery from blood with an antibiotic removal device.

Authors:  N J Lindsey; P E Riely
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

5.  Enhanced detection of bacteremia with a new BACTEC resin blood culture medium.

Authors:  P C Appelbaum; D G Beckwith; J R Dipersio; J W Dyke; J F Salventi; L L Stone
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

  5 in total
  6 in total

1.  Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins.

Authors:  Iris H Chen; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

2.  Evaluation of new blood culture processing systems.

Authors:  J A Moody; C E Fasching; C J Shanholtzer; D N Gerding; L R Peterson
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

3.  PCR and blood culture for detection of Escherichia coli bacteremia in rats.

Authors:  A Heininger; M Binder; S Schmidt; K Unertl; K Botzenhart; G Döring
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.

Authors:  R A Zabinski; A J Larsson; K J Walker; S S Gilliland; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

5.  Occurrence of bacteremia in hematologic patients.

Authors:  D D'Antonio; E Pizzigallo; A Iacone; M Dell'Isola; G Fioritoni; S Betti; A Piergallini; R Di Gianfilippo; P Olioso; G Torlontano
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

6.  Impact of low blood culture usage on rates of antimicrobial resistance.

Authors:  Cherry Lim; Viriya Hantrakun; Nittaya Teerawattanasook; Pramot Srisamang; Prapit Teparrukkul; Nithima Sumpradit; Paul Turner; Nicholas Pj Day; Ben S Cooper; Sharon J Peacock; Direk Limmathurotsakul
Journal:  J Infect       Date:  2020-12-02       Impact factor: 6.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.